PLK1 and diffuse large B-cell lymphoma: The cytotoxicity of the Ras-mimetic PI3K/PLK1 inhibitor rigosertib in diffuse large B-cell lymphoma (DLBCL) cells was associated with MYB suppression and inhibition of nuclear MYB translocation by sumoylation.